Nektar Therapeutics Reports First Quarter 2026 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 40.26 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.26 | 52 Week High | $19.98 | |||
| Open | $40.26 | 52 Week Low | $10.52 | |||
| Day High | $40.26 | P/E | N/A | |||
| Day Low | $40.26 | EPS | $-1.45 | |||
| Volume | 606 | |||||
